Mymetics Corp MYMX:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 02/16/24 EDT
0.01UNCH (UNCH)
52 week range
0.01 - 56.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.01
  • 52 Week High56.60
  • 52 Week High Date06/22/23
  • 52 Week Low0.01
  • 52 Week Low Date02/16/24

Key Stats

  • Market Cap1,518.80
  • Shares Out151,880.00
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.65
  • YTD % Change-99.69

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.01
  • 52 Week High56.60
  • 52 Week High Date06/22/23
  • 52 Week Low0.01
  • 52 Week Low Date02/16/24
  • Market Cap1,518.80
  • Shares Out151,880.00
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.65
  • YTD % Change-99.69

RATIOS/PROFITABILITY

  • EPS (TTM)-80.50
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.511M
  • ROE (TTM)-
  • Revenue (TTM)567,049.98
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,182.45%
  • Debt To Equity (MRQ)-99.39%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mymetics Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and...
Ronald Kempers
President, Chief Executive Officer, Chief Financial Officer
Address
Route De La Corniche 4
Epalinges
1066
Switzerland